On December 7, 2021, the Board of Directors of Zosano Pharma Corporation appointed Elaine Yang to serve as a member of the Board, effective immediately. Ms. Yang was appointed as a Class III director, to serve for an initial term expiring at the Company’s 2023 annual meeting of stockholders and until her successor is duly elected and qualified or until her earlier death, resignation or removal. Ms. Yang was also appointed to serve as a member of the Audit Committee of the Board. On December 10, 2021, Kleanthis Xanthopoulos delivered notice of his intention to resign from the Board effective as of December 31, 2021.